ONWD — Onward Medical NV Income Statement
0.000.00%
Last trade - 00:00
- €162.41m
- €134.47m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.4 | 10.8 | 15.5 | 28.5 | 32 |
Operating Profit | -8.4 | -10.8 | -15.5 | -28.5 | -32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.89 | -13.4 | -20 | -34.2 | -33.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.91 | -13.5 | -20 | -34.3 | -32.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -9.91 | -13.5 | -20 | -34.3 | -32.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.91 | -13.5 | -20 | -34.3 | -32.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.333 | -0.452 | -0.672 | -3.62 | -1.09 |